Paris - Delayed Quote EUR
ABIVAX Société Anonyme (ABVX.PA)
6.12
+0.08
+(1.32%)
At close: 5:35:22 PM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-154,072
-154,072
-97,130
-53,936
-45,048
Investing Cash Flow
15,762
15,762
-8,095
-12,026
-6,232
Financing Cash Flow
28,207
28,207
335,290
32,211
82,679
End Cash Position
144,221
144,221
251,942
26,950
60,701
Capital Expenditure
-643
-643
-265
-323
-47
Issuance of Capital Stock
434
434
353,387
46,374
69,683
Issuance of Debt
47,944
47,944
55,841
--
24,913
Repayment of Debt
-10,458
-10,458
-40,602
-9,711
-5,786
Free Cash Flow
-154,715
-154,715
-97,395
-54,259
-45,095
12/31/2021 - 6/26/2015
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
SIGHT.PA GenSight Biologics S.A.
0.2650
+15.97%
ADOC.PA Adocia SA
3.8800
-2.76%
GNFT.PA Genfit S.A.
3.2240
+1.45%
6IV.BE Inventiva SA
3.1650
-1.71%
NXOA.F Nicox S.A.
0.1760
0.00%
1F6.F Fermentalg SA
0.4045
+31.33%
DBV.F DBV Technologies S.A.
1.4900
+11.36%
1JK.F Apellis Pharmaceuticals, Inc.
15.80
+6.93%
GNRO.PA GeNeuro SA
0.0700
-10.26%
DBV.PA DBV Technologies S.A.
1.5440
+5.46%